153 related articles for article (PubMed ID: 25246915)
1. The correlation between follicular fluid pregnancy-associated plasma protein A levels, fertilization, and embryo quality in GnRH agonist and GnRH antagonist protocols in ART cycles.
Dehghani Firouzabadi R; Mohammadian F; Mashayekhy M; Davar R; Eftekhar M
Iran J Reprod Med; 2012 Sep; 10(5):477-82. PubMed ID: 25246915
[TBL] [Abstract][Full Text] [Related]
2. Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients.
Choi YS; Ku SY; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Hum Reprod; 2006 Aug; 21(8):2015-21. PubMed ID: 16601008
[TBL] [Abstract][Full Text] [Related]
3. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
4. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
5. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
[TBL] [Abstract][Full Text] [Related]
6. Impact of GnRH analogues on oocyte/embryo quality and embryo development in in vitro fertilization/intracytoplasmic sperm injection cycles: a case control study.
Murber A; Fancsovits P; Ledó N; Gilán ZT; Rigó J; Urbancsek J
Reprod Biol Endocrinol; 2009 Sep; 7():103. PubMed ID: 19781070
[TBL] [Abstract][Full Text] [Related]
7. Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
Xing W; Lin H; Li Y; Yang D; Wang W; Zhang Q
PLoS One; 2015; 10(10):e0140286. PubMed ID: 26468951
[TBL] [Abstract][Full Text] [Related]
8. Gonadotrophin-releasing hormone antagonists for assisted conception.
Al-Inany H; Aboulghar M
Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
[TBL] [Abstract][Full Text] [Related]
9. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
Orvieto R
J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
[TBL] [Abstract][Full Text] [Related]
10. GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation.
Geng Y; Xun Y; Hu S; Lai Q; Jin L
Gynecol Endocrinol; 2019 Apr; 35(4):309-313. PubMed ID: 30430883
[TBL] [Abstract][Full Text] [Related]
11. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
12. Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization-embryo transfer cycles.
Younis JS; Soltsman S; Izhaki I; Radin O; Bar-Ami S; Ben-Ami M
Fertil Steril; 2010 Sep; 94(4):1350-1355. PubMed ID: 19800061
[TBL] [Abstract][Full Text] [Related]
13. Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for in vitro fertilisation and embryo transfer.
Depalo R; Lorusso F; Palmisano M; Bassi E; Totaro I; Vacca M; Trerotoli P; Masciandaro P; Selvaggi L
Gynecol Endocrinol; 2009 May; 25(5):328-34. PubMed ID: 19340626
[TBL] [Abstract][Full Text] [Related]
14. Is the flexible GnRH antagonist protocol better suited for fresh eSET cycles?
Dahdouh EM; Gomes FL; Granger L; Carranza-Mamane B; Faruqi F; Kattygnarath TV; St-Michel P
J Obstet Gynaecol Can; 2014 Oct; 36(10):885-891. PubMed ID: 25375301
[TBL] [Abstract][Full Text] [Related]
15. Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial.
Giles J; Alama P; Gamiz P; Vidal C; Badia P; Pellicer A; Bosch E
Fertil Steril; 2021 Aug; 116(2):404-412. PubMed ID: 33814126
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments.
Maldonado LG; Franco JG; Setti AS; Iaconelli A; Borges E
Fertil Steril; 2013 May; 99(6):1615-22. PubMed ID: 23394779
[TBL] [Abstract][Full Text] [Related]
17. Substituting HCG with GnRH agonist to trigger final follicular maturation--a retrospective comparison of three different ovarian stimulation protocols.
Orvieto R; Rabinson J; Meltzer S; Zohav E; Anteby E; Homburg R
Reprod Biomed Online; 2006 Aug; 13(2):198-201. PubMed ID: 16895632
[TBL] [Abstract][Full Text] [Related]
18. ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial.
Mokhtar S; Sadeghi MR; Akhondi MM; Zafardoust S; Badenush B; Fatemi F; Nazari F; Kamali K; Mohammadzade A
J Reprod Infertil; 2015; 16(3):148-54. PubMed ID: 26913233
[TBL] [Abstract][Full Text] [Related]
19. [Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].
Kdous M; Chaker A; Bouyahia M; Zhioua F; Zhioua A
Tunis Med; 2009 Dec; 87(12):834-42. PubMed ID: 20209851
[TBL] [Abstract][Full Text] [Related]
20. Role of the proportion of dominant follicles in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer.
Lin HY; Li Y; Wang WJ; Qiu Q; Zhang QX; Li Y
Chin Med J (Engl); 2019 Jun; 132(12):1448-1453. PubMed ID: 31205103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
